Revolution Medicines Inc. (42Z)
FSX
Real-time Data
06:00 AM
Day's Range
179.9552 wk Range
30.40Overview - 42Z - Revolution Medicines Inc.
Key Statistics
Valuation
Enterprise Value
30.84B
P/E (Trailing)
‪-30.46‬
P/E (Forward)
‪-66.63‬
PEG Ratio
‪-0.22‬
Price / Book
‪17.41‬
EV / EBITDA
‪-22.31‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-30.12%‬
Return on Equity
‪-79.08%‬
Ownership
Shares Outstanding
214.24M
Float
184.45M
Held by Insiders
‪1.87%‬
Held by Institutions
‪100.98%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪162.94‬
200-Day Avg
‪110.39‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 42Z - Revolution Medicines Inc.
Peers - 42Z - Revolution Medicines Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
- 22UAFSXBioNTech SE25.39BMarket Cap+9.15%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
Profile Summary - 42Z - Revolution Medicines Inc.
About
Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for cancers driven by the RAS protein, one of the most common cancer drivers affecting approximately 30% of human cancer diagnoses. Founded in 2014 and headquartered in Redwood City, California, the company applies…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
